期刊
WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE
卷 3, 期 5, 页码 562-587出版社
WILEY
DOI: 10.1002/wsbm.137
关键词
-
资金
- Italian Ministry of Health and Education (Finanziamenti per la Ricerca di Base FIRB-IDEAS) [2008-RBID08C9N7]
- Italian Association for Cancer Research (AIRC, Milan, Italy)
- European Community [202272]
- Telethon Foundation [GPP08259]
- Cariplo Foundation, Milan
- University of Bari, Italy
Metabolic syndrome (MS) is a cluster of different diseases, namely central obesity, hypertension, hyperglycemia, and dyslipidemia, together with a pro-thrombotic and pro-inflammatory state. These metabolic abnormalities are often associated with an increased risk for cardiovascular disease (CVD) and cancer. Dietary and lifestyle modifications are currently believed more effective than pharmacological therapies in the management of MS patients. Nevertheless, the relatively low grade of compliance of patients to these recommendations, as well as the failure of current therapies, highlights the need for the discovery of new pharmacological and nutraceutic approaches. A deeper knowledge of the patho-physiological events that initiate and support the MS is mandatory. Lipid-sensing nuclear receptors (NRs) are the master transcriptional regulators of lipid and carbohydrate metabolism and inflammatory responses, thus standing as suitable targets. This review focuses on the physiological relevance of the NRs (peroxisome proliferator-activated receptors, liver X receptors, and farnesoid X receptor) in the control of whole-body homeostasis, with a special emphasis on lipid and glucose metabolism, and on the relationships between metabolic unbalances, systemic inflammation, and the onset of CVD. Future perspectives and possible clinical applications are also presented. (C) 2010 John Wiley & Sons, Inc. WIREs Syst Biol Med 2011 3 562-587 DOI: 10.1002/wsbm.137
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据